SCHEMBL2659243

SCHEMBL2659243

NC(=O)c1ccc(-c2cnns2)cc1-c1cnns1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
GAA P10253 2/20 0.45
MAPT P10636 2/20 0.45
HPGD P15428 2/20 0.45
HTT P42858 2/20 0.45
RUNX1 Q01196 2/20 0.45
CBFB Q13951 2/20 0.45
GFER P55789 1/20 0.45
CHUK O15111 2/20 0.39
NEK2 P51955 2/20 0.36
MKNK1 Q9BUB5 4/20 0.35
MKNK2 Q9HBH9 4/20 0.35
ALOX5AP P20292 1/20 0.35
FEN1 P39748 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
BCAT2 O15382 1/20 0.34
CHEK1 O14757 2/20 0.34
CHEK2 O96017 2/20 0.34
PRF1 P14222 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16718767 0.85 ALDH1A1 (0.45) ALDH1A1GAAMAPTHPGDHTT
SCHEMBL28940758 0.81 GPR52 (0.42) ALDH1A1GAAMAPTHPGDHTT
SCHEMBL16718820 0.80 CHEK1 (0.43) ALDH1A1GAAMAPTHPGDHTT
SCHEMBL2659245 0.80 BCAT2 (0.49) ALDH1A1GAAMAPTHPGDHTT
SCHEMBL4996647 0.76 MKNK1 (0.50) ALDH1A1GAAMAPTHPGDHTT
SCHEMBL16718821 0.73 ALDH1A1 (0.39) ALDH1A1GAAMAPTHPGDHTT
SCHEMBL9133011 0.67 CSNK2A1 (0.51) ALDH1A1GAAMAPTHPGDHTT
SCHEMBL16718819 0.67 WDR5 (0.44) ALDH1A1GAAMAPTHTTMEN1
SCHEMBL16718822 0.66 PARP1 (0.40) GAA
SCHEMBL9135746 0.66 MAPT (0.51) ALDH1A1GAAMAPTHPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2948458-A1 BTK INHIBITORS Merck Sharp & Dohme Corp. (US) 2015-12-02 EP claimed
WO-2014114185-A1 BTK INHIBITORS MERCK SHARP & DOHME CORP. (US) 2014-07-31 WO claimed
EP-3082821-A1 ANTIPARASITIC COMPOUNDS Avista Pharma Solutions, Inc. (US) 2016-10-26 EP disclosed
EP-2948458-A1 BTK INHIBITORS Merck Sharp & Dohme Corp. (US) 2015-12-02 EP disclosed
WO-2015073797-A1 ANTIPARASITIC COMPOUNDS SCYNEXIS INC. (US) 2015-05-21 WO disclosed
WO-2014114185-A1 BTK INHIBITORS MERCK SHARP & DOHME CORP. (US) 2014-07-31 WO disclosed
EP-1794156-A2 TROMBOPOIETIN RECEPTOR AGONISTS Pfizer Products Incorporated (US) 2007-06-13 EP disclosed
EP-1718624-A1 BENZAMIDE DERIVATIVES AND THEIR USE AS GLUCOKINASE ACTIVATING AGENTS AstraZeneca AB (SE) 2006-11-08 EP disclosed
WO-2006033005-A2 THROMBOPOIETIN RECEPTOR AGONISTS PFIZER PRODUCTS INC. (US) 2006-03-30 WO disclosed
WO-2005080359-A1 BENZAMIDE DERIVATIVES AND THEIR USE AS GLUCOKINAE ACTIVATING AGENTS ASTRAZENECA AB (SE) 2005-09-01 WO disclosed